News
Indena publishes Centella asiatica monograph
21 Feb 2019A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant.
A new monograph “Centella asiatica: entering a new era”, dedicated to Centella asiatica, has been recently published by Indena with the aim of crossing new boundaries of this important medicinal plant, widely used both in Indian Ayurvedic medicine and as a traditional medicine.
Centella asiatica, also known as “gotu kola”, is native to the wetlands of Southeast Asia and belongs to the Apiaceae family; it has been used for centuries in traditional medicine because of its anti-bacterial, anti-viral, anti-hypertensive, diuretic, antiulcer and anti-inflammatory properties. The most known active compounds are asiaticoside, madecassoside, asiatic acid and madecassic acid which promote the synthesis of collagen, regulate inflammation by normalizing the hyperproliferation of keratinocytes and are able to restore the natural homeostasis of the epidermis.The monograph “Centella asiatica: entering a new era” highlights that the pre-clinical and clinical studies available, while confirming the already known properties of the plant and its traditional uses, envisages new research scenarios and broader applications, from diabetic neuropathy to cardiovascular protection, from the treatment of burns to post-partum stretch marks. These areas could open new frontiers of research and development on a plant and its properties which have been known for centuries but whose potential has still more to offer.A first important new evidence is in the cardiovascular field, where the healing properties of Centella asiatica have inspired a new concept: the extract, similarly to the modulation of keloids on skin has been proven effective on atherosclerotic plaques as well – it was shown to prevent thrombotic or embolic complications by increasing the density and stability of atherosclerotic echolucent plaques in patients with atherosclerosis.Another field where Centella asiatica may qualify for broader applications is neurology: the plant’s effectiveness for the preservation of memory and cognitive functions is already known, since it is able to prevent neuronal degeneration, especially beta-amyloid. In addition, Centella asiatica appears to have a neuroprotective effect on stroke-induced cognitive impairment and in Parkinson’s disease. Moreover, Centella asiatica is now a potential candidate for the treatment of the reduction of neurological damage induced by diabetic hyperglycemia.“Indena is happy to achieve the fulfillment of the monograph ‘Centella asiatica: entering a new era’, which envisages new fields of application for such an important extract – comments Giada Maramaldi, Business Development Manager-Personal Care at Indena –We’ve been studying Centella asiatica for years to meet the needs of several conditions, and we’ll keep developing new products to take advantage of this medicinal plant’s amazing potential”.A further new evidence about Centella asiatica’s application is related to the treatment of stretch marks, visible linear depressions of the skin secondary to fibroblast dysfunction, very frequently appearing during or after pregnancy. They may derive from alterations in the connective tissue secondary to weight gain and hormonal imbalances due to the fact that elastin, collagen and all their components from the mother’s skin and veins are conveyed to the developing fetal structures. A pilot study, aiming to assess the efficacy, safety and tolerability of a Centella asiatica containing cream applied in the postpartum period, shows that topical treatment with the cream may offer greater benefit in terms of improvement of the stretch marks.A final but not inconsequential aspect is how the Centella asiatica supply chain is managed sustainably. Indena is sensitive to the importance of careful and accurate control of all supply chains and to manage its business considering the environmental and social issues. As for the Centella asiatica, Indena is promoting social projects in one of the main harvesting areas of the plant, the Alaotra Mangoro region of Madagascar.Related news
BelliWelli secures funding for retail and team expansion
2 Jan 2025
US fibre brand BelliWelli has confirmed a further $10 million series B investment from Invus. The investment will help the company further expand its presence in the US.
Read moreEU calls to harmonise allergen labelling increase
1 Jan 2025
Allergy awareness efforts focus on implementing a European reference laboratory and collaboration to standardise labels and support allergen identification.
Read moreJapanese study points to risk of excessive nutritional fortification
31 Dec 2024
Fortified foods and supplements are mainly beneficial but there is a small risk of over-supplementation – particularly for vitamin B6, a Japanese study has concluded.
Read moreIs it time for a global definition of whole grain?
30 Dec 2024
Amid a lack of harmonisation, the European Food Information Council (EUFIC) is calling for a global definition of the term whole grain to end consumer confusion.
Read moreEFSA publishes new food additive research on non-nutritive sweetener saccharine
27 Dec 2024
The European Food Safety Authority (EFSA) has released new recommendations on saccharin and its sodium, potassium and calcium salts (E 954) as food additives.
Read moreFDA delivers workshop on nutrition regulation and science
19 Dec 2024
The FDA hosted a nutrition regulatory science workshop exploring ultra-processed foods and emerging technologies, aiming to spotlight the relationship between nutrition, science, and evidence-based policies.
Read moreHow US soy exports shape Southeast Asian food
19 Dec 2024
As Southeast Asia and the US mark 20 years of trade, trends in soy, especially plant-based preferences, signal increasing demand for high-quality protein sources.
Read moreHormel Foods sells its Health Labs brands to Lyons Magnus
17 Dec 2024
Hormel Foods has confirmed the sale of its Hormel Health Labs division to Lyons Magnus, creating Lyons Health Labs. The strategic move aims to better position Lyons Magnus as a leading player in the growing US market for nutritional and health products...
Read moreNestlé releases products for pregnancy and fertility
13 Dec 2024
Building on in-house research, existing scientific evidence, and consumer demands, the global food company has developed products designed for mothers and babies.
Read moreConsumer awareness and transparency key factors in shift to natural-based emulsifiers
11 Dec 2024
The demand for natural-based emulsifiers in the food industry is surging as health concerns over the use of synthetic emulsifiers have consumers looking for alternatives.
Read more